Blog Post December 15, 2011
On December 12, the SEC sued Stiefel Laboratories and its then-CEO Charles Stiefel for defrauding plan participants and other shareholders of $110 million by purchasing shares from them at "severely undervalued prices." Stiefel Labs, which was privately held at the time of the purchases and is cu